Affordable Access

Publisher Website

A Sleeping Beauty DNA transposon-based genetic sensor for functional screening of vitamin D3 analogues

Authors
Journal
BMC Biotechnology
1472-6750
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Volume
11
Issue
1
Identifiers
DOI: 10.1186/1472-6750-11-33
Keywords
  • Research Article
Disciplines
  • Biology
  • Design
  • Medicine
  • Pharmacology

Abstract

Background Analogues of vitamin D3 are extensively used in the treatment of various illnesses, such as osteoporosis, inflammatory skin diseases, and cancer. Functional testing of new vitamin D3 analogues and formulations for improved systemic and topical administration is supported by sensitive screening methods that allow a comparative evaluation of drug properties. As a new tool in functional screening of vitamin D3 analogues, we describe a genomically integratable sensor for sensitive drug detection. This system facilitates assessment of the pharmacokinetic and pharmadynamic properties of vitamin D3 analogues. The tri-cistronic genetic sensor encodes a drug-sensoring protein, a reporter protein expressed from an activated sensor-responsive promoter, and a resistance marker. Results The three expression cassettes, inserted in a head-to-tail orientation in a Sleeping Beauty DNA transposon vector, are efficiently inserted as a single genetic entity into the genome of cells of interest in a reaction catalyzed by the hyperactive SB100X transposase. The applicability of the sensor for screening purposes is demonstrated by the functional comparison of potent synthetic analogues of vitamin D3 designed for the treatment of psoriasis and cancer. In clones of human keratinocytes carrying from a single to numerous insertions of the vitamin D3 sensor, a sensitive sensor read-out is detected upon exposure to even low concentrations of vitamin D3 analogues. In comparative studies, the sensor unveils superior potency of new candidate drugs in comparison with analogues that are currently in clinical use. Conclusions Our findings demonstrate the use of the genetic sensor as a tool in first-line evaluation of new vitamin D3 analogues and pave the way for new types of drug delivery studies in sensor-transgenic animals.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Vitamin D3 analogues.

on Clinics in dermatology 1997

Vitamin D3 analogues.

on Dermatologic Clinics October 1995

A lentiviral vector-based genetic sensor system fo...

on Experimental Dermatology March 2013
More articles like this..